Literature DB >> 28316514

Noninvasive Markers of Liver Fibrosis.

Nezam H Afdhal1.   

Abstract

Entities:  

Year:  2006        PMID： 28316514      PMCID： PMC5350221     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  11 in total

1.  Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis?

Authors:  Nezam H Afdhal
Journal:  Clin Chem       Date:  2004-08       Impact factor: 8.327

2.  Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

Authors:  Carlo Fabris; Carlo Smirne; Pierluigi Toniutto; Cosimo Colletta; Rachele Rapetti; Rosalba Minisini; Edmondo Falleti; Mario Pirisi
Journal:  Clin Biochem       Date:  2006-02-20       Impact factor: 3.281

3.  Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.

Authors:  F Imbert-Bismut; V Ratziu; L Pieroni; F Charlotte; Y Benhamou; T Poynard
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

4.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

5.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

6.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

7.  Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.

Authors:  Keyur Patel; Stuart C Gordon; Ira Jacobson; Christophe Hézode; Esther Oh; Katie M Smith; Jean-Michel Pawlotsky; John G McHutchison
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

8.  Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Authors:  Thomas B Kelleher; Shruti H Mehta; Ramakrishnan Bhaskar; Mark Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Journal:  J Hepatol       Date:  2005-04-25       Impact factor: 25.083

9.  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Authors:  Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

10.  Sampling variability of liver fibrosis in chronic hepatitis C.

Authors:  Pierre Bedossa; Delphine Dargère; Valerie Paradis
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.